Efficient virus recovery and impurity removal are challenges in the purification of viruses such as influenza A virus subtype H1N1. An overview of this development work of the vaccine production process using Nuvia HP-Q anion exchange chromatography resin is presented in this webinar. The focus of this work was to develop an efficient and cost-effective process while maintaining high quality and safety of the product. High purity and good overall yields were achieved with a single purification step. The purification step used here is scalable and can be adapted for large-scale production.